• 1. Essential effect of the electrolyte on the mechanical and chemical degradation of LiNi0.8Co0.15Al0.05O2 cathodes upon long-term cycling??
  Xiaoming Liu,Zachary D. Hood,Wangda Li,Donovan N. Leonard,Arumugam Manthiram,Miaofang Chi J. Mater. Chem. A, 2021,9, 2111-2119
• 2. Examination of deposit in commercial diluted phosphoric acid
  Analyst, 1880,5, 146-147
• 3. Evidence for the intrinsic nature of band-gap states electrochemically observed on atomically flat TiO2(110) surfaces?
  Shintaro Takata,Yoshihiro Miura Phys. Chem. Chem. Phys., 2014,16, 24784-24789
• 4. Excellent mechanical performance and enhanced dielectric properties of OBC/SiO2 elastomeric nanocomposites: effect of dispersion of the SiO2 nanoparticles?
  Xing Zhao,Lu Bai,Rui-Ying Bao,Zheng-Ying Liu,Ming-Bo Yang,Wei Yang RSC Adv., 2017,7, 46297-46305
• 5. Evidence of CO2 molecule acting as an electron acceptor on a nanoporous metal–organic-framework MIL-53 or Cr3+(OH)(O2C–C6H4–CO2)?
  Alexandre Vimont,Arnaud Travert,Philippe Bazin,Jean-Claude Lavalley,Marco Daturi,Christian Serre,Gérard Férey,Sandrine Bourrelly,Philip L. Llewellyn Chem. Commun., 2007, 3291-3293

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Pyrrolopyridines Pyrrolopyridines
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Pyrrolopyridines

Recent Advances in the Study of Ethyl 1H-Pyrrolo[3,2-c]pyridine-4-carboxylate (CAS: 1167056-36-1) and Its Applications in Chemical Biology and Medicine

Ethyl 1H-Pyrrolo[3,2-c]pyridine-4-carboxylate (CAS: 1167056-36-1) is a heterocyclic compound that has garnered significant attention in recent years due to its potential applications in medicinal chemistry and drug discovery. This compound, characterized by its pyrrolopyridine core, serves as a versatile scaffold for the synthesis of biologically active molecules. Recent studies have explored its utility in the development of kinase inhibitors, antimicrobial agents, and other therapeutic candidates. This research brief aims to summarize the latest findings related to this compound, highlighting its synthetic routes, biological activities, and potential clinical applications.

The synthesis of Ethyl 1H-Pyrrolo[3,2-c]pyridine-4-carboxylate has been optimized in several recent studies, with a focus on improving yield and scalability. One notable approach involves a multi-step reaction sequence starting from commercially available pyridine derivatives, followed by cyclization and esterification. Advanced catalytic methods, such as palladium-catalyzed cross-coupling reactions, have also been employed to introduce diverse functional groups onto the pyrrolopyridine core, enhancing its pharmacological properties. These synthetic advancements have facilitated the exploration of its structure-activity relationships (SAR) in drug design.

In the realm of biological activity, Ethyl 1H-Pyrrolo[3,2-c]pyridine-4-carboxylate has demonstrated promising results as a precursor for kinase inhibitors. Kinases play a critical role in cellular signaling pathways, and their dysregulation is implicated in various diseases, including cancer and inflammatory disorders. Derivatives of this compound have shown selective inhibition against specific kinase targets, such as JAK2 and EGFR, with nanomolar potency. Computational modeling and X-ray crystallography studies have provided insights into the binding modes of these inhibitors, aiding in the rational design of next-generation therapeutics.

Beyond its role in kinase inhibition, this compound has also been investigated for its antimicrobial properties. Recent in vitro studies have reported that certain derivatives exhibit broad-spectrum activity against Gram-positive and Gram-negative bacteria, as well as fungal pathogens. The mechanism of action appears to involve disruption of microbial cell wall synthesis, although further mechanistic studies are warranted. These findings suggest potential applications in addressing antibiotic resistance, a growing global health concern.

In conclusion, Ethyl 1H-Pyrrolo[3,2-c]pyridine-4-carboxylate (CAS: 1167056-36-1) represents a valuable scaffold in chemical biology and medicinal chemistry. Its synthetic versatility, combined with its diverse biological activities, positions it as a promising candidate for the development of novel therapeutics. Future research should focus on optimizing its pharmacokinetic properties and evaluating its efficacy in preclinical models to advance its translation into clinical applications.

• 853685-78-6(methyl 1H-pyrrolo[3,2-c]pyridine-2-carboxylate)
• 16732-80-2(Ethyl 4-methyl-1H-indole-2-carboxylate)
• 52280-53-2(1H-Benz[g]indole-2-carboxylic acid, ethyl ester)
• 1352394-18-3(Methyl 1H-pyrrolo[3,2-c]pyridine-6-carboxylate)
• 800401-64-3(Ethyl 1H-pyrrolo[3,2-c]pyridine-2-carboxylate)
• 65550-34-7(2-Quinolinecarboxylicacid, ethyl ester, hydrochloride (1:1))
• 3770-50-1(Ethyl indole-2-carboxylate)
• 107384-68-9(ethyl 3aH-pyrrolo[3,2-c]pyridine-6-carboxylate)
• 52280-52-1(3H-Benz[e]indole-2-carboxylic acid, ethyl ester)
• 1040682-92-5(Methyl 1H-pyrrolo[3,2-c]pyridine-4-carboxylate)